Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Detalles Bibliográficos
Autores principales: Festa, Stefano, Aratari, Annalisa, De Biasio, Fabiola, Fascì-Spurio, Federica, Papi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247967/
https://www.ncbi.nlm.nih.gov/pubmed/32527654
http://dx.doi.org/10.1016/j.dld.2020.05.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247967/
https://www.ncbi.nlm.nih.gov/pubmed/32527654
http://dx.doi.org/10.1016/j.dld.2020.05.037

Ejemplares similares